Last reviewed · How we verify

NCT06170307

Left Atrial Function of COVID-19-recovered Patients During the Surge of Omicron Variants

Completed Last updated 17 December 2024
What this trial tests

trial testing two-dimensional speckle tracking echocardiography in COVID-19 Pandemic in 150 participants. Completed in 20 August 2024.

Timeline
20 November 2023
Primary endpoint
20 July 2024
20 August 2024

Quick facts

Lead sponsorHaiyan Wang
StatusCompleted
Study typeOBSERVATIONAL
Enrollment150
Start date20 November 2023
Primary completion20 July 2024
Estimated completion20 August 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Haiyan Wang

Who can join

Adults 18 to 70, any sex, with COVID-19 Pandemic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to retrospectively analyze left atrial function in mild to moderate COVID-19-recovered patients. The main questions it aims to answer are: * Whether left atrial function is involved in patients with mild to moderate COVID-19 after recovery. * What are the factors that may be associated with persistent heart-related symptoms (including chest pain, chest tightness, palpitations, shortness of breath, or postural tachycardia) in patients with mild to moderate COVID-19 ? Participants will undergo transthoracic echocardiography to obtain conventional ultrasound parameters, two-dimensional strain parameters will been obtained through software post-processing, and general clinical data and laboratory test results will been obtained.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Myocardial Dysfunction and Risk of Long COVID in Patients Recovered From Mild and Moderate COVID-19.
    Zhou B, Zhang Y, Han S, Zhang J, et al · · 2025 · cited 1× · PMID 40029146 · DOI 10.1111/echo.70120

Verify or expand the search:

Other trials of two-dimensional speckle tracking echocardiography

Trials testing the same drug.

Other recruiting trials for COVID-19 Pandemic

Currently open trials in the same condition.

Other Haiyan Wang trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06170307.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing